Indeed, Wendt et al. [148] proposed that p130Cas alters the balance between canonical and noncanonical TGF-β signaling, in a way that impairs the tumor suppressor functions of TGF-β during breast cancer progression. This evidence concerns the gene TGFB1 and breast carcinoma.